Pitches and Keynote Speakers Are Confirmed for Blue Magic Netherlands on November 17 
The 34th Hong Kong International Optical Fair opens today 
CMS (867.HK/8A8.SG): Ruxolitinib Phosphate Cream Approved in Singapore, Filling Gap in Vitiligo Treatment 
Payment Cards Group (A3A PayTech) Joins HKMA’s Agentic Finance Expert Group 
Three Million Fewer Members, JPY97.5 Billion More Revenue: APEC Lands in Shenzhen and China’s Gym Industry Is Being Recomposed KBRA Releases RMBS Credit Indices (KCI) for January 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for January 2022. The indices track…
Harris Williams Advises Forefront Dermatology on its Pending Sale to Partners Group
RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it…
HARMAY Raises $200 Million in Series C and D Funding
BEIJING–(BUSINESS WIRE)–HARMAY, the new retail beauty brand, has concluded its Series C and D rounds…
KBRA Releases Solar Loan Index for January 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its inaugural solar loan index publication, providing monthly credit trends of…
Carvana Named #1 Retailer on Forbes 2022 America’s Best Employers List
The fastest organic growth auto retailer in U.S. history also ranks top 10 overall among…
AACN Announces 2022 Election Results for Board of Directors and Nominating Committee
WASHINGTON–(BUSINESS WIRE)–The American Association of Colleges of Nursing (AACN) is pleased to announce the results…
Pennsylvania Lumbermens Mutual Insurance Company Goes Live with Insurity’s Cloud-Based Sure Underwriting to Speed and Strengthen Underwriting through Automation
Insurity’s cloud-native, configurable underwriting solution enables Pennsylvania Lumbermens Mutual Insurance Company to automate core processes…
BioSyent Adopts Advance Notice By-law
MISSISSAUGA, Ontario, Feb. 11, 2022 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
Vaxxinity’s COVID-19 Vaccine Candidate UB-612 Produces High Levels of Neutralizing Antibodies Against Omicron and Other Variants of Concern
Investigator-sponsored studies show UB-612 induces high antibody activity against multiple variants, including Alpha, Beta, Delta,…
Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab
NEW YORK, Feb. 11, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
Amolyt Pharma to Participate at Three Upcoming Investor Conferences
LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Amolyt Pharma, a global…
Coherus BioSciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 17th, 2022
REDWOOD CITY, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today…
NRx Reports Remarks by Israel Institute for Biological Research on the future of the BriLife™ Covid-19 Investigational Vaccine
Remarks by Dr. Shmuel Yitzhaki, as published in Globes, an Israeli business newspaper BriLife vaccine…
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage…
Vor to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR), a clinical-stage cell…
Replimune to Present at the 11th Annual SVB Leerink Global Healthcare Conference
WOBURN, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) — Replimune Group, Inc. (NASDAQ: REPL), a clinical…
QBREXZA® (Rapifort® Wipes 2.5%) Receives Manufacturing and Marketing Approval in Japan Triggering $2.5 Million Milestone Payment to Journey Medical Corporation
SCOTTSDALE, Ariz., Feb. 11, 2022 (GLOBE NEWSWIRE) — Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical”),…
Cytek Biosciences to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
FREMONT, Calif., Feb. 11, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
Immutep Granted Australian Patent for Eftilagimod Alpha, a Soluble LAG-3 Protein, in Combination with a PD-1 Pathway Inhibitor
SYDNEY, AUSTRALIA, Feb. 11, 2022 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep”…
Spectral Medical Reports Progress on Tigris Clinical Trial
Patient mortality data continues to exceed expectations Recent FDA approved SOFA amendment contributing to increased…